Valuation: Cann Group Limited

Market Cap 8.3M 5.95M 5.1M 4.77M 4.37M 8.19M 569M 56.36M 21.98M 286M 22.35M 21.86M 946M P/E 2024
-0.23x
P/E 2025 -0.24x
Enterprise Value 84.13M 60.31M 51.66M 48.34M 44.25M 83.04M 5.77B 571M 223M 2.9B 226M 222M 9.59B EV / Sales 2024
4.54x
EV / Sales 2025 6.2x
Free-Float
82.48%
Yield 2024 *
-
Yield 2025 -
Current month+20.00%
1 month-25.00%
3 months-40.00%
6 months-57.14%
Current year-66.67%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.19
5 years 0
Extreme 0.002
0.44
10 years 0
Extreme 0.002
4.55
Manager TitleAgeSince
Chief Executive Officer - 01/04/2024
Director of Finance/CFO - 14/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 79 10/02/2025
Director/Board Member - 08/09/2020
Director/Board Member 59 31/03/2025
Date Insider Type Main position Quantity % Market Cap.
6/12/24 A Buy

Chief Executive Officer

205,500 0.0469%
8/1/23 A Buy

Director

165,515 0.0341%
8/1/23 A Buy

Chairman

284,091 0.0585%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-80.00%-97.60% 3.57M
+5.84%+7.51%-5.56%+197.92% 333M
+3.01%+1.18%-21.20%-15.76% 175M
+0.51%+0.51%+6.42%+84.26% 143M
+2.17%+11.90%-27.69%-14.55% 95.51M
0.00%+5.36%+13.46%+28.26% 53.07M
Average +1.92%+4.41%-19.09%+30.42% 133.73M
Weighted average by Cap. +3.43%+5.23%-8.54%+93.31%

Financials

2024 2025
Net sales 18.36M 13.16M 11.27M 10.55M 9.65M 18.12M 1.26B 125M 48.59M 632M 49.41M 48.34M 2.09B 13.25M 9.5M 8.14M 7.61M 6.97M 13.08M 909M 89.96M 35.08M 457M 35.67M 34.89M 1.51B
Net income -51.24M -36.73M -31.46M -29.44M -26.95M -50.57M -3.51B -348M -136M -1.77B -138M -135M -5.84B -22.34M -16.02M -13.72M -12.84M -11.75M -22.05M -1.53B -152M -59.15M -770M -60.14M -58.83M -2.55B
Net Debt 70.83M 50.77M 43.49M 40.69M 37.25M 69.9M 4.86B 481M 187M 2.44B 191M 186M 8.07B 75.83M 54.35M 46.56M 43.57M 39.88M 74.84M 5.2B 515M 201M 2.61B 204M 200M 8.64B
Logo Cann Group Limited
Cann Group Limited is an Australia-based company, which is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the Company, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research and good manufacturing practices (GMP) manufacturing facilities are near Mildura, Victoria.
Employees
-
Date Price Change Volume
21/08/26 A$0.003000 0.00% 15,571
20/08/26 A$0.003000 0.00% 30,834
19/08/26 A$0.003000 -14.29% 842,673
18/08/26 A$0.003500 +16.67% 505,738
17/08/26 A$0.003000 0.00% 741,719